A literature review on off-label drug use in children, Eur J Pediatr, vol.164, pp.552-560, 2005. ,
Regulation (EC) No 1901/2006 of the european parliament and of the council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive, Official Journal of the European Union, issue.726, 1901. ,
Pediatric drugs -a review of commercially available oral formulations, J Pharm Sci, vol.97, pp.1731-74, 2008. ,
Why do we need hospital pharmacy preparation ?, EJHP, vol.19, pp.467-468, 2012. ,
, The Complete Drug Reference, p.4792, 2017.
Morphine versus clonidine for neonatal abstinence syndrome, Pediatrics, vol.135, pp.383-91, 2015. ,
,
Clonidine as an adjunct therapy to opioids for neonatal abstinence syndrome: a randomized, controlled trial, Pediatrics, vol.123, pp.849-56, 2009. ,
Efficacy of clonidine versus phenobarbital in reducing neonatal morphine sulfate therapy days for neonatal abstinence syndrome. A prospective randomized clinical trial, J Perinatol, vol.33, pp.954-963, 2013. ,
Multimodal intrathecal analgesia in refractory cancer pain, Scand J Pain, vol.14, pp.39-43, 2017. ,
Clonidine premedication for postoperative analgesia in children, Cochrane Database Syst Rev, vol.28, p.9633, 2014. ,
When do children convert from liquid antiretroviral to solid formulations?, Pharm World Sci, vol.27, pp.399-402, 2005. ,
A benefit/risk approach towards selecting appropriate pharmaceutical dosage forms -An application for paediatric dosage form selection, Int J Pharm, vol.435, pp.115-138, 2012. ,
, European Medicines Agency: Committee for medicinal products for human use. Reflection paper: formulations of choice for the paediatric population. 28 juil, 2006.
,
, Development and validation of a paediatric oral formulation of clonidine hydrochloride, Int J Pharm, vol.433, pp.119-139, 2012.
Stability of Extemporaneously Compounded Clonidine in Glass and Plastic Bottles and Plastic Syringes, Can J Hosp Pharm, vol.67, pp.308-318, 2014. ,
Stability of an extemporaneously compounded clonidine hydrochloride oral liquid, Am J Hosp Pharm, vol.49, pp.122-125, 1992. ,
Stability of Clonidine Suspension in Oral Plastic Syringes, Am J Health-Syst Pharm, vol.71, pp.657-61, 2014. ,
Stability and osmolality of extemporaneously prepared clonidine oral liquid for neonates, Ann Pharmacother, vol.50, pp.244-249, 2016. ,
Oestrogenic activity of parabens in mcf7 human breast cancer cells, J Steroid Biochem Mol Biol, vol.80, pp.49-60, 2002. ,
,
, Bull Cancer, vol.95, pp.871-880, 2008.
Effects of butylparaben on the male reproductive system in rats, Toxicol Ind Health, vol.17, pp.31-39, 2001. ,
Effects of butyl paraben on the male reproductive system in mice, Arch Toxicol, vol.76, pp.423-429, 2002. ,
Educational paper: formulation-related issues in pediatric clinical pharmacology, Eur J Pediatr, vol.172, pp.717-737, 2013. ,
Methodological guidelines for stability studies of hospital pharmaceutical preparations, 2013. ,
Harmonization of strategies for the validation of quantitative analytical procedures, J Pharm Biomed Anal, vol.45, pp.70-81, 2007. ,
Harmonization of strategies for the validation of quantitative analytical procedures, J Pharm Biomed Anal, vol.45, pp.82-96, 2007. ,
Harmonization of strategies for the validation of quantitative analytical procedures, J Pharm Biomed Anal, vol.36, pp.579-86, 2004. ,
Harmonization of strategies for the validation of quantitative analytical procedures: A SFSTP proposal, J Pharm Biomed Anal, vol.48, pp.760-71, 2008. ,
European Pharmacopeia 9 th , 2017. 5.1.4 "Microbiological quality of non-sterile pharmaceutical preparations and substances for pharmaceutical use, R1, vol.2, 2005. ,
, European Pharmacopeia 9 th , 2017. 2.6.12 "microbiological examination of non-sterile products: microbial enumeration tests" monograph
, European Pharmacopeia 9 th , 2017. 2.6.13 "microbiological examination of non-sterile products: tests for specified micro-organisms
Handbook of pharmaceutical excipients. Monograph potassium sorbate, 1216. ,
Stability of Admixture Containing Morphine ,
Clonidine Hydrochloride in an Implantable Infusion System, J Pain and Symptom Manag, vol.28, pp.603-614, 2004. ,
Stability and compatibility of morphineclonidine admixtures in an implantable infusion system, J Pain Symptom Manag, vol.25, pp.464-471, 2003. ,
Chemical Stability of Ziconotide-Clonidine Hydrochloride Admixtures with and without Morphine Sulfate during Simulated Intrathecal Administration, Neuromodulation, vol.10, pp.6-11, 2007. ,
Development of Clonidine Hydrochloride Injections for Epidural and Intrathecal Administration, Int J Pharm Compd, vol.1, pp.274-281, 1997. ,
Physical and Chemical Stability of Low and High Concentrations of Morphine Sulfate with Clonidine Hydrochloride Packaged in Plastic Syringes, Int J Pharm Compd, vol.6, pp.66-75, 2002. ,
Stability indicating isocratic RP-HPLC method development and validation for the simultaneous analysis of clonidine and chlorthalidone in pharmaceutical formulation, Indo Am J Pharm Res, vol.5, pp.3226-3262, 2015. ,
Prediction of solubility and permeability class membership: provisional BCS classification of the world's top oral drugs, AAPS, vol.11, issue.4, pp.740-746, 2009. ,
CloSed Consortium. A mini-review of non-parenteral clonidine preparations for paediatric sedation, J Pharm Pharmacol, vol.69, pp.398-405, 2017. ,
, The fourth report on the Diagnosis, evaluation, and treatment of high blood pressure in children and adolescents, Pediatrics, vol.114, pp.555-576, 2004.